These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
225 related articles for article (PubMed ID: 38728506)
41. Serious antimicrobial resistance status of pathogens causing hospital-acquired lower respiratory tract infections in North China. Wang Y; Zhang R; Li W; Feng Y; Leng T J Int Med Res; 2009; 37(3):899-907. PubMed ID: 19589276 [TBL] [Abstract][Full Text] [Related]
42. [Analysis of distribution and drug resistance of pathogens isolated from 541 hospitalized children with burn infection]. Dai JX; Li L; Xu L; Chen ZH; Li XY; Liu M; Wen YQ; Chen XD Zhonghua Shao Shang Za Zhi; 2016 Nov; 32(11):670-675. PubMed ID: 27894388 [No Abstract] [Full Text] [Related]
43. Antimicrobial susceptibility of bacterial pathogens associated with community-acquired respiratory tract infections in Asia: report from the Community-Acquired Respiratory Tract Infection Pathogen Surveillance (CARTIPS) study, 2009-2010. Wang H; Chen M; Xu Y; Sun H; Yang Q; Hu Y; Cao B; Chu Y; Liu Y; Zhang R; Yu Y; Sun Z; Zhuo C; Ni Y; Hu B; Tan TY; Hsueh PR; Wang JH; Ko WC; Chen YH; Wahjono H Int J Antimicrob Agents; 2011 Nov; 38(5):376-83. PubMed ID: 21880469 [TBL] [Abstract][Full Text] [Related]
44. Antimicrobial susceptibility testing results from 13 hospitals in Viet Nam: VINARES 2016-2017. Vu TVD; Choisy M; Do TTN; Nguyen VMH; Campbell JI; Le TH; Nguyen VT; Wertheim HFL; Pham NT; Nguyen VK; van Doorn HR; Antimicrob Resist Infect Control; 2021 May; 10(1):78. PubMed ID: 33971969 [TBL] [Abstract][Full Text] [Related]
45. Antimicrobial susceptibility profiles of gram-negative bacteria causing infections collected across India during 2014-2016: Study for monitoring antimicrobial resistance trend report. Veeraraghavan B; Jesudason MR; Prakasah JAJ; Anandan S; Sahni RD; Pragasam AK; Bakthavatchalam YD; Selvakumar RJ; Dhole TN; Rodrigues C; Roy I; Joshi S; Chaudhuri BN; Chitnis DS Indian J Med Microbiol; 2018; 36(1):32-36. PubMed ID: 29735823 [TBL] [Abstract][Full Text] [Related]
46. Prevalence and antimicrobial resistance of bacterial meningitis in China from 2017 to 2021: a multicenter retrospective study. Zhang C; Li Z; Wang M; Wang S J Infect Dev Ctries; 2024 Aug; 18(8):1233-1240. PubMed ID: 39288385 [TBL] [Abstract][Full Text] [Related]
47. [Analysis of resistance tendency of bloodstream-infecting pathogens in China]. Lü Y; Li Y; Xue F; Zhang XZ; Hu YJ; Jin YF; Chu YZ; Hu ZD; Zhao JH; Pan SY; Zhao WS; Hu BJ; Yu YS; Deng QL; Yang J; Li Y; Liu WE; Lü XJ; Yang YJ; Zhou L; Dong F; Fu WL; Xu XL; Pei FY; Yang B; Meng L; Ji P; Wang S Zhonghua Jie He He Hu Xi Za Zhi; 2013 Jun; 36(6):411-9. PubMed ID: 24103203 [TBL] [Abstract][Full Text] [Related]
48. [Epidemiological analysis of pathogens causing bloodstream infections in department of hematology in Guangdong Province]. Zhuo CY; Guo YY; Liu NJ; Liu BM; Xiao SN; Zhang Y; Guo XC; Li DN; Tan SY; He NH; Mai Y; Guan J; Zhuo C Zhonghua Xue Ye Xue Za Zhi; 2020 Dec; 41(12):996-1001. PubMed ID: 33445846 [No Abstract] [Full Text] [Related]
49. [Impact of antimicrobial stewardship program on antimicrobial usage and detection rate of multidrug-resistant gram-negative bacteria]. Xu YL; Hu LM; Xie ZZ; Dong YW; Dong L Zhonghua Er Ke Za Zhi; 2019 Jul; 57(7):553-558. PubMed ID: 31269557 [No Abstract] [Full Text] [Related]
50. Activity of fosfomycin against nosocomial multiresistant bacterial pathogens from Croatia: a multicentric study. Bielen L; Likić R; Erdeljić V; Mareković I; Firis N; Grgić-Medić M; Godan A; Tomić I; Hunjak B; Markotić A; Bejuk D; Tičić V; Balzar S; Bedenić B Croat Med J; 2018 Apr; 59(2):56-64. PubMed ID: 29740989 [TBL] [Abstract][Full Text] [Related]
51. The interface between COVID-19 and bacterial healthcare-associated infections. O'Toole RF Clin Microbiol Infect; 2021 Dec; 27(12):1772-1776. PubMed ID: 34111586 [TBL] [Abstract][Full Text] [Related]
52. [Analysis of pathogen spectrum and antimicrobial resistance of pathogens associated with hospital-acquired infections collected from 11 teaching hospitals in 2018]. Li SG; Liao K; Su DH; Zhuo C; Chu YZ; Hu ZD; Xu XL; Zhang R; Liu WE; Lu BH; Zeng J; Jin Y; Wang H Zhonghua Yi Xue Za Zhi; 2020 Dec; 100(47):3775-3783. PubMed ID: 33379842 [No Abstract] [Full Text] [Related]
53. Antimicrobial Resistance Patterns of Common Gram-Negative Microorganisms Isolated from Patients with Lower Respiratory Tract Infections in a Teaching Hospital in Vietnam. Le HH; Nguyen AV; Vu LH; Nguyen VTH; Pham HQ; Le HV; Nguyen ST; Le HT; Dinh HV; Le NV; Le TD; Le MN; Nguyen VH; Hoang KT; Le HHL Jpn J Infect Dis; 2024 May; 77(3):144-154. PubMed ID: 38296537 [TBL] [Abstract][Full Text] [Related]
55. Rates of antimicrobial resistance among common bacterial pathogens causing respiratory, blood, urine, and skin and soft tissue infections in pediatric patients. Jones ME; Karlowsky JA; Draghi DC; Thornsberry C; Sahm DF; Bradley JS Eur J Clin Microbiol Infect Dis; 2004 Jun; 23(6):445-55. PubMed ID: 15156358 [TBL] [Abstract][Full Text] [Related]
56. Antimicrobial susceptibility of gram-negative and gram-positive bacteria collected from countries in Eastern Europe: results from the Tigecycline Evaluation and Surveillance Trial (T.E.S.T.) 2004-2010. Balode A; Punda-Polić V; Dowzicky MJ Int J Antimicrob Agents; 2013 Jun; 41(6):527-35. PubMed ID: 23590898 [TBL] [Abstract][Full Text] [Related]
57. Bloodstream Infections in the Intensive Care Unit: a Single-Center Retrospective Bacteriological Analysis Between 2007 and 2019. Guzek A; Rybicki Z; Woźniak-Kosek A; Tomaszewski D Pol J Microbiol; 2022 Jun; 71(2):263-277. PubMed ID: 35716169 [TBL] [Abstract][Full Text] [Related]
58. In vitro activity of ceftaroline, ceftazidime-avibactam, and comparators against Gram-positive and -negative organisms in China: the 2018 results from the ATLAS program. Jia P; Zhu Y; Zhang H; Cheng B; Guo P; Xu Y; Yang Q BMC Microbiol; 2022 Oct; 22(1):234. PubMed ID: 36182895 [TBL] [Abstract][Full Text] [Related]
59. Sulopenem: An Intravenous and Oral Penem for the Treatment of Urinary Tract Infections Due to Multidrug-Resistant Bacteria. Zhanel GG; Pozdirca M; Golden AR; Lawrence CK; Zelenitsky S; Berry L; Schweizer F; Bay D; Adam H; Zhanel MA; Lagacé-Wiens P; Walkty A; Irfan N; Naber K; Lynch JP; Karlowsky JA Drugs; 2022 Apr; 82(5):533-557. PubMed ID: 35294769 [TBL] [Abstract][Full Text] [Related]
60. Antimicrobial activity of tigecycline tested against nosocomial bacterial pathogens from patients hospitalized in the intensive care unit. Sader HS; Jones RN; Dowzicky MJ; Fritsche TR Diagn Microbiol Infect Dis; 2005 Jul; 52(3):203-8. PubMed ID: 16105565 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]